AU648842B2
(en)
*
|
1990-09-21 |
1994-05-05 |
Amgen, Inc. |
Enzymatic synthesis of oligonucleotides
|
US5645987A
(en)
*
|
1990-09-21 |
1997-07-08 |
Amgen Inc. |
Enzymatic synthesis of oligonucleotides
|
US5683874A
(en)
*
|
1991-03-27 |
1997-11-04 |
Research Corporation Technologies, Inc. |
Single-stranded circular oligonucleotides capable of forming a triplex with a target sequence
|
US6261808B1
(en)
|
1992-08-04 |
2001-07-17 |
Replicon, Inc. |
Amplification of nucleic acid molecules via circular replicons
|
US6096880A
(en)
*
|
1993-04-15 |
2000-08-01 |
University Of Rochester |
Circular DNA vectors for synthesis of RNA and DNA
|
US6077668A
(en)
*
|
1993-04-15 |
2000-06-20 |
University Of Rochester |
Highly sensitive multimeric nucleic acid probes
|
US7135312B2
(en)
|
1993-04-15 |
2006-11-14 |
University Of Rochester |
Circular DNA vectors for synthesis of RNA and DNA
|
US5648211A
(en)
*
|
1994-04-18 |
1997-07-15 |
Becton, Dickinson And Company |
Strand displacement amplification using thermophilic enzymes
|
US5854033A
(en)
|
1995-11-21 |
1998-12-29 |
Yale University |
Rolling circle replication reporter systems
|
WO1997020948A1
(en)
|
1995-12-05 |
1997-06-12 |
Koch Joern Erland |
A cascade nucleic acid amplification reaction
|
GB9609213D0
(en)
*
|
1996-05-02 |
1996-07-03 |
Tepnel Medical Ltd |
Amplification of nucleic acids
|
JP3415995B2
(ja)
*
|
1996-06-10 |
2003-06-09 |
科学技術振興事業団 |
高分子マイクロ遺伝子重合体の作成方法
|
GB9626074D0
(en)
*
|
1996-12-16 |
1997-02-05 |
Cytocell Ltd |
Nucleic acids amplification assay
|
EP1985714B1
(de)
*
|
1998-03-25 |
2012-02-29 |
Olink AB |
Zwei Affinitätsproben und Rolling-Circle-Replikation zur Detektion eines Zielmoleküls verwendende Verfahren und Kit
|
US6316229B1
(en)
|
1998-07-20 |
2001-11-13 |
Yale University |
Single molecule analysis target-mediated ligation of bipartite primers
|
US6287824B1
(en)
|
1998-09-15 |
2001-09-11 |
Yale University |
Molecular cloning using rolling circle amplification
|
JP2002525078A
(ja)
*
|
1998-09-15 |
2002-08-13 |
イェール ユニバーシティ |
人工的長末端反復配列
|
EP1121469A2
(de)
*
|
1998-10-12 |
2001-08-08 |
Attomol GmbH Molekulare Diagnostika |
Verfahren und kit zum direkten nachweis von nukleotidsequenzen, aminosäuresequenzen oder antigenen
|
GB9822777D0
(en)
*
|
1998-10-20 |
1998-12-16 |
Tepnel Medical Ltd |
Template chain reaction
|
US6830884B1
(en)
|
1998-12-15 |
2004-12-14 |
Molecular Staging Inc. |
Method of amplification
|
US20020025519A1
(en)
|
1999-06-17 |
2002-02-28 |
David J. Wright |
Methods and oligonucleotides for detecting nucleic acid sequence variations
|
CA2387576C
(en)
|
1999-10-18 |
2011-05-10 |
Prince Henry's Institute Of Medical Research |
Immuno-interactive fragments of the .alpha.c subunit of inhibin
|
JP2003532380A
(ja)
*
|
1999-12-02 |
2003-11-05 |
モレキュラー ステージング,インコーポレイテッド |
線状自己アニーリングセグメントからの一本鎖環状dnaの産出
|
US7947291B2
(en)
|
2000-01-25 |
2011-05-24 |
The University Of Queensland |
Modified surface antigen
|
US6221603B1
(en)
*
|
2000-02-04 |
2001-04-24 |
Molecular Dynamics, Inc. |
Rolling circle amplification assay for nucleic acid analysis
|
AU2001238106A1
(en)
*
|
2000-02-10 |
2001-08-20 |
The Penn State Research Foundation |
Method for amplifying full length single strand polynucleotide sequences
|
US6291187B1
(en)
*
|
2000-05-12 |
2001-09-18 |
Molecular Staging, Inc. |
Poly-primed amplification of nucleic acid sequences
|
US6323009B1
(en)
|
2000-06-28 |
2001-11-27 |
Molecular Staging, Inc. |
Multiply-primed amplification of nucleic acid sequences
|
AU2001271722B2
(en)
|
2000-06-30 |
2006-04-13 |
Qiagen, Gmbh |
Signal amplification with lollipop probes
|
US6312913B1
(en)
*
|
2000-07-21 |
2001-11-06 |
Incyte Genomics, Inc. |
Method for isolating and characterizing nucleic acid sequences
|
AUPR030900A0
(en)
|
2000-09-22 |
2000-10-12 |
Queensland University Of Technology |
Growth factor complex
|
US6573051B2
(en)
|
2001-03-09 |
2003-06-03 |
Molecular Staging, Inc. |
Open circle probes with intramolecular stem structures
|
AUPR446701A0
(en)
|
2001-04-18 |
2001-05-17 |
Gene Stream Pty Ltd |
Transgenic mammals for pharmacological and toxicological studies
|
US7838270B2
(en)
|
2001-05-22 |
2010-11-23 |
The University Of Chicago |
Target-dependent transcription using deletion mutants of N4 RNA polymerase
|
GB2378245A
(en)
*
|
2001-08-03 |
2003-02-05 |
Mats Nilsson |
Nucleic acid amplification method
|
JP2005535629A
(ja)
|
2002-06-27 |
2005-11-24 |
ザ ユニバーシティ オブ クイーンズランド |
分化調節薬剤およびその使用法
|
WO2011063477A1
(en)
|
2009-11-30 |
2011-06-03 |
Queensland University Of Technology |
Fibronectin: growth factor chimeras
|
AU2003900481A0
(en)
|
2003-02-05 |
2003-02-20 |
Queensland University Of Technology |
Synthetic modulators of cell migration and growth
|
US20100143442A1
(en)
|
2003-02-05 |
2010-06-10 |
Queensland University Of Technology |
Growth factor complexes and modulation of cell migration and growth
|
US8043834B2
(en)
|
2003-03-31 |
2011-10-25 |
Qiagen Gmbh |
Universal reagents for rolling circle amplification and methods of use
|
AU2003902253A0
(en)
|
2003-05-12 |
2003-05-29 |
The University Of Queensland |
Method for increasing product yield
|
WO2005108608A1
(en)
*
|
2004-05-10 |
2005-11-17 |
Kabushiki Kaisha Dnaform |
Method for isolating nucleic acid isoforms
|
CA2591659A1
(en)
|
2004-12-17 |
2006-06-22 |
Monash University |
Regulation of metalloprotease cleavage of cell surface proteins
|
EP1833994A4
(de)
*
|
2005-01-04 |
2009-09-02 |
Hitachi Chemical Co Ltd |
Rolling-circle-verstärkung einer primer-erzeugung
|
GB0504774D0
(en)
*
|
2005-03-08 |
2005-04-13 |
Lingvitae As |
Method
|
EP1863908B1
(de)
|
2005-04-01 |
2010-11-17 |
Qiagen GmbH |
Reverse transkription und amplifikation von rna bei simultaner degradierung von dna
|
EP1871896B1
(de)
|
2005-04-12 |
2015-06-03 |
Olink AB |
Zirkulare Sonden und deren Verwendung zur Identifizierung von Biomolekülen
|
WO2006108423A2
(en)
|
2005-04-12 |
2006-10-19 |
In Situ Rcp A/S Under Founding |
Methods for production of oligonucleotides
|
DK1907583T4
(da)
|
2005-06-15 |
2020-01-27 |
Complete Genomics Inc |
Enkeltmolekyle-arrays til genetisk og kemisk analyse
|
EP1762627A1
(de)
|
2005-09-09 |
2007-03-14 |
Qiagen GmbH |
Verfahren zur Aktivierung einer Nukleinsäure für eine Polymerase-Reaktion
|
CA2624324A1
(en)
|
2005-10-06 |
2007-04-19 |
Lucigen Corporation |
Thermostable viral polymerases and methods of use
|
US7960104B2
(en)
*
|
2005-10-07 |
2011-06-14 |
Callida Genomics, Inc. |
Self-assembled single molecule arrays and uses thereof
|
SG10201405158QA
(en)
*
|
2006-02-24 |
2014-10-30 |
Callida Genomics Inc |
High throughput genome sequencing on dna arrays
|
US7501254B2
(en)
|
2006-07-20 |
2009-03-10 |
Ghc Technologies, Inc. |
Methods and compositions for amplification and capture of nucleic acid sequences
|
EP2058396A4
(de)
*
|
2006-08-31 |
2010-06-30 |
Toyo Seikan Kaisha Ltd |
Nukleinsäureamplifikationsverfahren
|
WO2008070352A2
(en)
|
2006-10-27 |
2008-06-12 |
Complete Genomics, Inc. |
Efficient arrays of amplified polynucleotides
|
US20100203051A1
(en)
|
2007-05-31 |
2010-08-12 |
The University Of Queensland |
Diagnostic markers for ankylosing spondylitis and uses thereof
|
GB0901593D0
(en)
|
2009-01-30 |
2009-03-11 |
Touchlight Genetics Ltd |
Production of closed linear DNA
|
GB201013153D0
(en)
|
2010-08-04 |
2010-09-22 |
Touchlight Genetics Ltd |
Primer for production of closed linear DNA
|
EP3578205A1
(de)
|
2010-08-06 |
2019-12-11 |
ModernaTX, Inc. |
Pharmazeutische zusammensetzungen enthaltenbearbeitete nukleinsäuren und ihre medizinische verwendung
|
HUE058896T2
(hu)
|
2010-10-01 |
2022-09-28 |
Modernatx Inc |
N1-metil-pszeudo-uracilt tartalmazó ribonukleinsavak és azok felhasználásai
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
RU2648950C2
(ru)
|
2011-10-03 |
2018-04-02 |
Модерна Терапьютикс, Инк. |
Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
|
EP2791160B1
(de)
|
2011-12-16 |
2022-03-02 |
ModernaTX, Inc. |
Modifizierte mrna zusammensetzungen
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
AU2013243951A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of secreted proteins
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
EP2920324B1
(de)
|
2012-11-14 |
2017-12-27 |
Olink Bioscience AB |
Lokalisiertes rca-basiertes verstärkungsverfahren
|
EP2922554B1
(de)
|
2012-11-26 |
2022-02-23 |
ModernaTX, Inc. |
Terminal modifizierte rns
|
EP3587592A1
(de)
*
|
2013-03-15 |
2020-01-01 |
Theranos IP Company, LLC |
Nukleinsäureamplifikation
|
WO2014145298A1
(en)
|
2013-03-15 |
2014-09-18 |
Theranos, Inc. |
Nucleic acid amplification
|
US10450595B2
(en)
|
2013-03-15 |
2019-10-22 |
Theranos Ip Company, Llc |
Nucleic acid amplification
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
EP2971123B1
(de)
|
2013-03-15 |
2021-05-05 |
Labrador Diagnostics LLC |
Nukleinsäureamplifikation
|
WO2015034925A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
EP3042208A4
(de)
|
2013-09-06 |
2017-04-19 |
Theranos, Inc. |
Systeme und verfahren zur erkennung von infektionskrankheiten
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
EA201690675A1
(ru)
|
2013-10-03 |
2016-08-31 |
Модерна Терапьютикс, Инк. |
Полинуклеотиды, кодирующие рецептор липопротеинов низкой плотности
|
GB201321123D0
(en)
|
2013-11-29 |
2014-01-15 |
Linea Ab Q |
Amplification of circular molecules
|
EP3256591A4
(de)
|
2015-02-13 |
2018-08-08 |
Translate Bio Ma, Inc. |
Hybride oligonukleotide und verwendungen davon
|
US20170151281A1
(en)
|
2015-02-19 |
2017-06-01 |
Batu Biologics, Inc. |
Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer
|
DE112016003948T5
(de)
|
2015-08-31 |
2018-05-09 |
City Of Sapporo |
Molekulare verfahren zum beurteilen einer urothelialen erkrankung
|
GB201614023D0
(en)
|
2016-08-16 |
2016-09-28 |
Olink Bioscience Ab |
Double-stranded circle probes
|
EP3558355A2
(de)
|
2016-12-23 |
2019-10-30 |
CureVac AG |
Henipavirus-impfstoff
|
WO2018115527A2
(en)
|
2016-12-23 |
2018-06-28 |
Curevac Ag |
Mers coronavirus vaccine
|
EP3558354A1
(de)
|
2016-12-23 |
2019-10-30 |
CureVac AG |
Impfstoff gegen das lassa-virus
|
CA3050614A1
(en)
|
2017-03-17 |
2018-09-20 |
Curevac Ag |
Rna vaccine and immune checkpoint inhibitors for combined anticancer therapy
|
WO2018209398A1
(en)
|
2017-05-17 |
2018-11-22 |
Microbio Pty Ltd |
Biomarkers and uses thereof
|
CN111328287A
(zh)
|
2017-07-04 |
2020-06-23 |
库瑞瓦格股份公司 |
新型核酸分子
|
US20200306286A1
(en)
|
2017-12-15 |
2020-10-01 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising circular polyribonucleotides and uses thereof
|
EP3773702A2
(de)
|
2018-04-05 |
2021-02-17 |
CureVac AG |
Neue gelbfieber-nukleinsäuremoleküle zur impfung
|
CN112292395A
(zh)
|
2018-04-17 |
2021-01-29 |
库瑞瓦格股份公司 |
用于疫苗接种的新型rsv rna分子和组合物
|
EP3813874A1
(de)
|
2018-06-27 |
2021-05-05 |
CureVac AG |
Neuartige lassa-virus-rna-moleküle und zusammensetzungen zur impfung
|
AU2019410737A1
(en)
|
2018-12-21 |
2021-06-10 |
CureVac SE |
RNA for malaria vaccines
|
WO2020161342A1
(en)
|
2019-02-08 |
2020-08-13 |
Curevac Ag |
Coding rna administered into the suprachoroidal space in the treatment of ophtalmic diseases
|
ES2928724T3
(es)
|
2019-03-01 |
2022-11-22 |
Flagship Pioneering Innovations Vi Llc |
Polirribonucleótidos y usos cosméticos de los mismos
|
EP3930683A1
(de)
|
2019-03-01 |
2022-01-05 |
Flagship Pioneering Innovations VI, LLC |
Zusammensetzungen, verfahren und kits zur verabreichung von polyribonukleotiden
|
CA3128626A1
(en)
|
2019-03-04 |
2020-09-10 |
Flagship Pioneering Innovations Vi, Llc |
Circular polyribonucleotides and pharmaceutical compositions thereof
|
CN113661242A
(zh)
|
2019-03-25 |
2021-11-16 |
旗舰创业创新第六有限责任公司 |
包含经修饰的环状多核糖核苷酸的组合物及其用途
|
AU2020292427A1
(en)
|
2019-06-14 |
2022-01-06 |
Flagship Pioneering Innovations Vi, Llc |
Circular RNAs for cellular therapy
|
AU2020296190A1
(en)
|
2019-06-19 |
2022-01-06 |
Flagship Pioneering Innovations Vi, Llc |
Methods of dosing circular polyribonucleotides
|
EP3986469A1
(de)
|
2019-06-19 |
2022-04-27 |
Flagship Pioneering Innovations VI, LLC |
Zusammensetzungen mit kreisförmigen polyribonukleotiden zur proteinmodulation und deren verwendungen
|
CA3144902A1
(en)
|
2019-08-14 |
2022-01-19 |
Andreas Thess |
Rna combinations and compositions with decreased immunostimulatory properties
|
TW202142239A
(zh)
|
2020-01-29 |
2021-11-16 |
美商旗艦先鋒創新有限責任公司 |
包含環狀多核糖核苷酸之組合物之遞送
|
US20230181620A1
(en)
|
2020-01-29 |
2023-06-15 |
Flagship Pioneering Innovations Vi, Llc |
Compositions for translation and methods of use thereof
|
EP4153224A1
(de)
|
2020-05-20 |
2023-03-29 |
Flagship Pioneering Innovations VI, LLC |
Coronavirus-antigen-zusammensetzungen und ihre verwendungen
|
TW202208629A
(zh)
|
2020-05-20 |
2022-03-01 |
美商旗艦先鋒創新有限責任公司 |
免疫原性組成物及其用途
|
US20230203192A1
(en)
|
2020-05-20 |
2023-06-29 |
Flagship Pioneering, Inc. |
Compositions and methods for producing human polyclonal antibodies
|
MX2023002439A
(es)
|
2020-09-03 |
2023-05-09 |
Flagship Pioneering Innovations Vi Llc |
Composiciones immunogénicas y usos de las mismas.
|
CA3193508A1
(en)
|
2020-09-23 |
2022-03-31 |
Myeloid Therapeutics, Inc. |
Improved methods and compositions for expression of nucleic acids in cells
|
MX2023005201A
(es)
|
2020-11-04 |
2023-06-28 |
Myeloid Therapeutics Inc |
Composiciones de proteinas de fusion quimerica modificadas por ingenieria y metodos de uso de las mismas.
|
AU2022398478A1
(en)
|
2021-11-24 |
2024-06-13 |
Flagship Pioneering Innovations Vi, Llc |
Coronavirus immunogen compositions and their uses
|
CA3238735A1
(en)
|
2021-11-24 |
2023-06-01 |
Jennifer A. Nelson |
Immunogenic compositions and their uses
|
AU2022397292A1
(en)
|
2021-11-24 |
2024-05-30 |
Flagship Pioneering Innovations Vi, Llc |
Varicella-zoster virus immunogen compositions and their uses
|
TW202340460A
(zh)
|
2021-12-17 |
2023-10-16 |
美商旗艦先鋒創新有限責任公司 |
用於在變性條件下富集環狀rna之方法
|
TW202340461A
(zh)
|
2021-12-22 |
2023-10-16 |
美商旗艦先鋒創新有限責任公司 |
用於純化多核糖核苷酸之組成物和方法
|
TW202342064A
(zh)
|
2021-12-23 |
2023-11-01 |
美商旗艦先鋒創新有限責任公司 |
編碼抗融合多肽之環狀多核糖核苷酸
|
WO2024097664A1
(en)
|
2022-10-31 |
2024-05-10 |
Flagship Pioneering Innovations Vi, Llc |
Compositions and methods for purifying polyribonucleotides
|